Our Research

Three researchers work in the lab

At the 鶹 鶹 we carry out world-leading innovative research into the molecular mechanisms that underlie normal cellular processes and functions.

A particular focus is how we age and studying the underlying mechanisms controlling this process, for example how older people respond differently to infection compared to the young. To answer these questions we examine the regulation of gene expression, the control of cell function by signalling processes and the complex cellular interactions that produce an effective immune response. Read more about our .

Three themes are central to our research remit: epigenetics – how the genome is regulated without change to the DNA sequence of genes, cell signalling – how cells respond to cues from their external environment; and immunology – how our immune systems are formed, how they function and how they are affected by age. The expert teams grouped together under these themes undertake core research supported by strategic funding to the 鶹 from BBSRC, a part of UKRI, and also secure funding competitively from other sources. Exciting research spanning these themes brings together unique and complimentary perspectives to deliver new insights.

Our research spans the whole life course and is as relevent to understanding the earliest moments of life as it is to delivering better health in later years. Our work uses a variety of experimental models and is supported by the cutting-edge capabilities of our .

A visual introduction to The 鶹 鶹

Understanding ageing to increase healthspan

One of the major achievements of the modern era is the extension of the human lifespan through improvements in medical care, nutrition, sanitation and access to clean water. Over the last century, life expectancy at birth in the UK has risen by almost 30 years so that both men and women can now expect to live well into their 80s. This is shifting population demographics; almost 1 in 5 of the UK’s total population is aged 65 or over and this is expected to rise to 1 in 4 by 2050.

These gains in lifespan have not been matched by gains in healthspan. Progressive physiological and physical decline are a part of normal ageing but increased age also increases the risk and incidence of numerous debilitating diseases and ailments including macular degeneration, dementia and cancer. Older people are also more susceptible to a variety of infections and exhibit reduced antibody responses to vaccinations due to the age-related decline in immune function.

Ageing is a societal grand challenge, scientific research offers the possibility to help more of us understand how to remain healthy, happy and active throughout life. If we are to understand and ameliorate these deficits in healthspan we need to understand the complex alterations in biological functions that lead to ageing.


Healthy Ageing Research

Research programmes

Showcasing our research

The 鶹’s research is summarised in our most recent 2021-2022 Review, which in addition to celebrating research progress, also recognises work and achievements from across our community. The 鶹’s research and people are showcased through feature articles in the report, presenting recent discoveries, profiles on group leaders and reflections on our culture.


Part of the research and innovation ecosystem

Much of our research involves collaborations with the University of Cambridge, with other research institutions in the Cambridge region and with universities and organisations worldwide, and all our PhD students are affiliated to Cambridge Colleges.

Where the knowledge generated from the 鶹’s research has potential for application, our scientists work with clinicians or with pharmaceutical and biotechnology companies to translate the research for social and economic benefit. This process is managed by 鶹 鶹 Enterprise Ltd (BIE), the 鶹’s wholly-owned trading subsidiary.

The 鶹 forms the cornerstone of the vibrant , home to some 60 start-up and growing bioscience companies, which is managed by 鶹 Research Campus Ltd.